目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product
1.2.2. End Use
1.3. Regional Scope
1.4. Estimates and Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Market Model
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
1.12. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising demand for cell therapies
3.2.1.2. Advancements in research and development for cell-based therapies
3.2.1.3. Technological Innovation
3.2.2. Market Restraint Analysis
3.2.2.1. High cost associated with the production and procurement of raw materials
3.2.2.2. Stringent regulations associated with cell therapies
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis
4.1. Product Segment Dashboard
4.2. Cell Therapy Raw Materials Market: Product Movement Analysis
4.3. Cell Therapy Raw Materials Market Size & Trend Analysis, By Product, 2018 to 2030 (USD Million)
4.4. Media
4.4.1. Media Market, 2018 - 2030 (USD Million)
4.5. Sera
4.5.1. Sera Market, 2018 - 2030 (USD Million)
4.6. Cell Culture Supplements
4.6.1. Cell Culture Supplements Market, 2018 - 2030 (USD Million)
4.7. Antibodies
4.7.1. Antibodies Market, 2018 - 2030 (USD Million)
4.8. Reagents & Buffers
4.8.1. Reagents & Buffers Market, 2018 - 2030 (USD Million)
4.9. Others
4.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. End Use Business Analysis
5.1. Cell Therapy Raw Materials Market: End Use Movement Analysis
5.2. Biopharmaceutical & Pharmaceutical Companies
5.2.1. Biopharmaceutical & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
5.3. CROs & CMOs
5.3.1. CROs & CMOs Market, 2018 - 2030 (USD Million)
5.4. Others
5.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis
6.1. Cell Therapy Raw Materials Market Share By Region, 2024 & 2030
6.2. North America
6.2.1. North America Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. Key Country Dynamics
6.2.2.2. Competitive Scenario
6.2.2.3. Regulatory Framework
6.2.2.4. U.S. Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Key Country Dynamics
6.2.3.2. Competitive Scenario
6.2.3.3. Regulatory Framework
6.2.3.4. Canada Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Key Country Dynamics
6.2.4.2. Competitive Scenario
6.2.4.3. Regulatory Framework
6.2.4.4. Mexico Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. UK Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Germany Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. France Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Key Country Dynamics
6.3.5.2. Competitive Scenario
6.3.5.3. Regulatory Framework
6.3.5.4. Italy Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Key Country Dynamics
6.3.6.2. Competitive Scenario
6.3.6.3. Regulatory Framework
6.3.6.4. Spain Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Key Country Dynamics
6.3.7.2. Competitive Scenario
6.3.7.3. Regulatory Framework
6.3.7.4. Denmark Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Key Country Dynamics
6.3.8.2. Competitive Scenario
6.3.8.3. Regulatory Framework
6.3.8.4. Sweden Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Key Country Dynamics
6.3.9.2. Competitive Scenario
6.3.9.3. Regulatory Framework
6.3.9.4. Norway Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. Japan Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. China Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. India Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Australia Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.4.6. Thailand
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Thailand Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.4.7. South Korea
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. South Korea Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Brazil Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. Argentina Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.6. MEA
6.6.1. MEA Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. South Africa Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Saudi Arabia Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. UAE Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Kuwait Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.3. Company Position Analysis, 2024
7.4. Company Profiles
7.4.1. Thermo Fisher Scientific Inc.
7.4.1.1. Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Merck KGaA
7.4.2.1. Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Actylis.
7.4.3.1. Overview
7.4.3.2. Product Benchmarking
7.4.3.3. Strategic Initiatives
7.4.4. ACROBiosystems
7.4.4.1. Overview
7.4.4.2. Product Benchmarking
7.4.4.3. Strategic Initiatives
7.4.5. STEMCELL Technologies
7.4.5.1. Overview
7.4.5.2. Product Benchmarking
7.4.5.3. Strategic Initiatives
7.4.6. Grifols, S.A.
7.4.6.1. Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Charles River Laboratories
7.4.7.1. Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. RoosterBio, Inc.
7.4.8.1. Overview
7.4.8.2. Product Benchmarking
7.4.8.3. Strategic Initiatives
7.4.9. PromoCell GmbH
7.4.9.1. Overview
7.4.9.2. Product Benchmarking
7.4.9.3. Strategic Initiatives
7.4.10. Danaher
7.4.10.1. Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Strategic Initiatives
7.4.11. Sartorius Stedim Biotech
7.4.11.1. Overview
7.4.11.2. Financial Performance
7.4.11.3. Product Benchmarking
7.4.11.4. Strategic Initiatives

List of Tables
Table 1 Global cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 2 Global cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 3 Global cell therapy raw materials market, by region, 2018 - 2030 (USD Million)
Table 4 North America cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
Table 5 North America cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 6 North America cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 7 U.S. cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 8 U.S. cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 9 Canada cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 10 Canada cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 11 Mexico cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 12 Mexico cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 13 Europe cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
Table 14 Europe cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 15 Europe cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 16 UK cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 17 UK cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 18 Germany cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 19 Germany cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 20 France cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 21 France cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 22 Italy cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 23 Italy cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 24 Spain cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 25 Spain cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 26 Denmark cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 27 Denmark cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 28 Sweden cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 29 Sweden cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 30 Norway cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 31 Norway cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 32 Asia Pacific cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
Table 33 Asia Pacific cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 34 Asia Pacific cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 35 Japan cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 36 Japan cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 37 China cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 38 China cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 39 India cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 40 India cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 41 Australia cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 42 Australia cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 43 South Korea cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 44 South Korea cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 45 Thailand cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 46 Thailand cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 47 Latin America cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
Table 48 Latin America cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 49 Latin America cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 50 Brazil cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 51 Brazil cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 52 Argentina cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 53 Argentina cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 54 Middle East & Africa cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
Table 55 Middle East & Africa cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 57 South Africa cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 58 South Africa cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 59 Saudi Arabia cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 60 Saudi Arabia cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 61 UAE cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 62 UAE cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 63 Kuwait cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
Table 64 Kuwait cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
Table 65 Key companies undertaking acquisitions
Table 66 Key companies launching new products/services
Table 67 Key companies undertaking collaborations and partnerships
Table 68 Key companies undertaking other initiatives

List of Figures
Fig. 1 Market research process
Fig. 2 Cell therapy raw materials market segmentation
Fig. 3 Data analysis models
Fig. 4 Market formulation and validation
Fig. 5 Data validating & publishing
Fig. 6 Market research process
Fig. 7 Information procurement
Fig. 8 Primary research
Fig. 9 Value-chain-based sizing & forecasting
Fig. 10 QFD modelling for market share assessment
Fig. 11 Market formulation & validation
Fig. 12 Commodity flow analysis
Fig. 13 Market snapshot
Fig. 14 Segment snapshot
Fig. 15 Segment snapshot
Fig. 16 Competitive landscape snapshot
Fig. 17 Market trends & outlook
Fig. 18 Porter’s five force analysis
Fig. 19 SWOT analysis, by factor (Political, Economic, Social, Technological, and Legal)
Fig. 20 Cell therapy raw materials market: product outlook key takeaways
Fig. 21 Cell therapy raw materials market: product movement analysis
Fig. 22 Media market, 2018 - 2030 (USD Million)
Fig. 23 Sera market, 2018 - 2030 (USD Million)
Fig. 24 Cell culture supplements market, 2018 - 2030 (USD Million)
Fig. 25 Antibodies market, 2018 - 2030 (USD Million)
Fig. 26 Reagents & buffers market, 2018 - 2030 (USD Million)
Fig. 27 Others market, 2018 - 2030 (USD Million)
Fig. 28 Cell therapy raw materials market: end Use outlook key takeaways
Fig. 29 Cell therapy raw materials market: end Use movement analysis
Fig. 30 Biopharmaceutical & pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 31 CROs & CMOs supplements market, 2018 - 2030 (USD Million)
Fig. 32 Others supplements market, 2018 - 2030 (USD Million)
Fig. 33 Cell therapy raw materials market revenue, by region, 2022 & 2030 (USD Million)
Fig. 34 Regional marketplace: key takeaways
Fig. 35 North America cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 US cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 US Key country dynamics
Fig. 38 Canada cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Canada Key country dynamics
Fig. 40 Mexico cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Mexico Key country dynamics
Fig. 42 Europe cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 UK cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 UK Key country dynamics
Fig. 45 Germany cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Germany Key country dynamics
Fig. 47 France cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 France Key country dynamics
Fig. 49 Spain cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Spain Key country dynamics
Fig. 51 Italy cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Italy Key country dynamics
Fig. 53 Denmark cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Denmark Key country dynamics
Fig. 55 Sweden cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Sweden Key country dynamics
Fig. 57 Norway cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Norway Key country dynamics
Fig. 59 Asia Pacific cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Japan cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Japan Key country dynamics
Fig. 62 China cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 China Key country dynamics
Fig. 64 India cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 India Key country dynamics
Fig. 66 Australia cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Australia Key country dynamics
Fig. 68 South Korea cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 South Korea Key country dynamics
Fig. 70 Thailand cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Thailand Key country dynamics
Fig. 72 Latin America cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Brazil cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Brazil Key country dynamics
Fig. 75 Argentina cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Argentina Key country dynamics
Fig. 77 MEA cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 South Africa cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 South Africa Key country dynamics
Fig. 80 Saudi Arabia cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Saudi Arabia Key country dynamics
Fig. 82 UAE cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 UAE Key country dynamics
Fig. 84 Kuwait cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Kuwait Key country dynamics
Fig. 86 Market participant categorization
Fig. 87 Strategic framework